enVVeno Medical Corporation (NASDAQ: NVNO) Stock Information | RedChip

enVVeno Medical Corporation (NASDAQ: NVNO) Listen to this Section


$5.33
-0.1150 ( -2.11% ) 23.1K

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Market Data


Open


$5.33

Previous close


$5.44

Volume


23.1K

Market cap


$70.12M

Day range


$5.23 - $5.44

52 week range


$3.40 - $6.97

Insider Ownership Transactions

Total Amount Purchased: -638,758.00 | $ -3,401,386.35

Date Type Amount Purchased Purchaser
2024-03-15 Sale -8334.00 Alavi Hamed
2023-12-07 Sale -100000.00 Alavi Hamed
2023-12-07 Sale -300000.00 BERMAN ROBERT ANDREW
2023-12-07 Sale -13856.00 Duhay Francis
2023-12-07 Sale -100000.00 Glickman Marc H.
2023-12-07 Sale -13856.00 Gray Robert
2023-12-07 Sale -13856.00 Jenusaitis Matthew
2023-12-07 Sale -13856.00 Shrivastava Sanjay
2023-12-07 Sale -75000.00 Glynn Craig

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 42 Jul 31, 2024
10-q Quarterly Reports 46 May 08, 2024
8-k 8K-related 15 Apr 24, 2024
4 Insider transactions 1 Mar 15, 2024
8-k 8K-related 16 Mar 06, 2024
10-k Annual reports 71 Feb 29, 2024
4 Insider transactions 1 Dec 07, 2023
4 Insider transactions 1 Dec 07, 2023
4 Insider transactions 1 Dec 07, 2023
4 Insider transactions 1 Dec 07, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.